Cancer
Malignant Prostate Neoplasm
CI-CAN-00005927Explore in graph →
Top-level1,377 active trials24 approved drugs58 evidence items
- NCIt
- C7378
- ICD-10
- C61
- DOID
- 10283
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00005927Explore in graph →
Clinical trials
5,979 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (730)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06359821 | Evaluate Safety, Whole-Body Distribution and Radiation Dosimetry in Metastatic Castration Resistant Prostate Cancer | completed | Early Phase 1 | 4 | Sichuan UniversityOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT06756334 | Head-to-head Comparison of [18F]AlF-PSMA-N5 With [18F]F-DCFPyL PET/CT in PCa Diagnosis, Recurrence, and Metastasis | recruiting | Early Phase 1 | 30 | Anhui Provincial HospitalOTHER_GOV | 1 | Jan 3, 2025 | clinicaltrials |
| NCT03232164 | PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancer | completed | Early Phase 1 | 126 | University of Wisconsin, MadisonOTHER | 1 | Dec 12, 2024 | clinicaltrials |
| NCT05707182 | 18F-rhPSMA-7.3 PET/MRI in Prostate Cancer Active Surveillance: a Pilot Study | withdrawn | Early Phase 1 | 0 | University of Alabama at BirminghamOTHER | 0 | Sep 25, 2024 | clinicaltrials |
| NCT06612580 | 68Ga-AAZTA-NI-093 PET/CT: First-in-human Study | recruiting | Early Phase 1 | 10 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | Sep 25, 2024 | clinicaltrials |
| NCT04067960 | Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer | completed | Early Phase 1 | 197 | Mayo ClinicOTHER | 1 | Aug 14, 2024 | clinicaltrials |
| NCT06546527 | Study of [177Lu]Lu-PSMA-137 In Metastatic Castrate Resistant Prostate Cancer（mCRPC） | not yet recruiting | Early Phase 1 | 12 | Peking University First HospitalOTHER | 0 | Aug 9, 2024 | clinicaltrials |
| NCT05549024 | 68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients | recruiting | Early Phase 1 | 90 | Peking Union Medical College HospitalOTHER | 1 | Jul 5, 2024 | clinicaltrials |
| NCT06462495 | Head-to-head Comparison of [18F]F-PSMA-N5 With [18F]F-PSMA-1007 PET/CT in PCa Diagnosis, Recurrence, and Metastasis | unknown | Early Phase 1 | 30 | Anhui Provincial HospitalOTHER_GOV | 1 | Jun 17, 2024 | clinicaltrials |
| NCT06462508 | Head-to-head Comparison of [18F]F-PSMA-N5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis | unknown | Early Phase 1 | 30 | Anhui Provincial HospitalOTHER_GOV | 1 | Jun 17, 2024 | clinicaltrials |
| NCT03275857 | Cisplatin in Castration Resistant Prostate Cancer | completed | Early Phase 1 | 12 | University of RochesterOTHER | 1 | Jun 10, 2024 | clinicaltrials |
| NCT06437496 | 68Ga-AAZTA-093 PET/CT: First-in-human Study | unknown | Early Phase 1 | 30 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | May 31, 2024 | clinicaltrials |
| NCT02113657 | T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancer | completed | Early Phase 1 | 30 | M.D. Anderson Cancer CenterOTHER | 1 | May 24, 2024 | clinicaltrials |
| NCT03358563 | Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancer | completed | Early Phase 1 | 30 | University of Wisconsin, MadisonOTHER | 1 | May 3, 2024 | clinicaltrials |
| NCT04726033 | 64Cu-TLX592 Phase I Safety, PK, Biodistribution and Dosimetry Study (CUPID Study)(CUPID) | completed | Early Phase 1 | 14 | Telix Pharmaceuticals (Innovations) Pty LimitedINDUSTRY | 1 | May 1, 2024 | clinicaltrials |
| NCT05238831 | SMMART Adaptive Clinical Treatment (ACT) Trial | withdrawn | Early Phase 1 | 0 | OHSU Knight Cancer InstituteOTHER | 0 | Jan 23, 2024 | clinicaltrials |
| NCT05773703 | Exploratory PK and Imaging Study of PSMA-Targeted Trillium Compounds and PTI-122 in Metastatic Prostate Cancer | completed | Early Phase 1 | 23 | Ratio Therapeutics, Inc.INDUSTRY | 1 | Dec 13, 2023 | clinicaltrials |
| NCT05725070 | Phase 0/1 Study of 212Pb-NG001 in mCRPC | completed | Early Phase 1 | 3 | ARTBIO Inc.INDUSTRY | 1 | Oct 6, 2023 | clinicaltrials |
| NCT05567679 | A Study of Tazemetostat (Tazverik) Before Prostatectomy in Men With Prostate Cancer | withdrawn | Early Phase 1 | 0 | Edwin Posadas, MDOTHER | 1 | Sep 22, 2023 | clinicaltrials |
| NCT06050239 | Study of 177Lu-PSMA-0057 in Metastatic Prostate Cancer | unknown | Early Phase 1 | 10 | Nanjing First Hospital, Nanjing Medical UniversityOTHER | 1 | Sep 22, 2023 | clinicaltrials |
| NCT04831541 | 68Ga-PSMA-11 PET/CT in Patients With Various Types of Cancer | unknown | Early Phase 1 | 600 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | Sep 21, 2023 | clinicaltrials |
| NCT01253213 | BR55 in Prostate Cancer: an Exploratory Clinical Trial | completed | Early Phase 1 | 26 | Bracco Diagnostics, IncINDUSTRY | 1 | Aug 1, 2023 | clinicaltrials |
| NCT05558956 | Total Body PET-CT Imaging of Prostate Cancer Using Illuccix | unknown | Early Phase 1 | 100 | BAMF HealthOTHER | 1 | Jul 27, 2023 | clinicaltrials |
| NCT05955677 | Head-to-head Comparison of [68Ga]Ga-PSMA-D5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis | unknown | Early Phase 1 | 100 | Anhui Provincial HospitalOTHER_GOV | 1 | Jul 21, 2023 | clinicaltrials |
| NCT04658849 | Insulin Resistance Following ADT for Prostate CA | withdrawn | Early Phase 1 | 0 | St. Louis UniversityOTHER | 1 | May 15, 2023 | clinicaltrials |
| NCT04158817 | 68Ga-THP-PSMA PET/CT in Prostate Cancer: Clinical Stage and Restage | completed | Early Phase 1 | 8 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT05815394 | 177Lu-labeled NY108 SPECT Imaging in Patients | unknown | Early Phase 1 | 10 | Affiliated Hospital of Jiangnan UniversityOTHER | 1 | Apr 18, 2023 | clinicaltrials |
| NCT04282967 | Streaming Web-based Exercise At Home: A Pilot Study | completed | Early Phase 1 | 12 | Celina ShirazipourOTHER | 1 | Apr 11, 2023 | clinicaltrials |
| NCT04976257 | Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusion | completed | Early Phase 1 | 5 | Ryan Kohlbrenner, MDOTHER | 1 | Apr 7, 2023 | clinicaltrials |
| NCT02534376 | Cellular Effect of Cholesterol-Lowering Prior to Prostate Removal | completed | Early Phase 1 | 63 | Cedars-Sinai Medical CenterOTHER | 1 | Feb 22, 2023 | clinicaltrials |
| NCT02826382 | Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041 | completed | Early Phase 1 | 14 | Five Eleven Pharma, Inc.INDUSTRY | 1 | Jan 12, 2023 | clinicaltrials |
| NCT03692663 | Study of Anti-PSMA CAR NK Cell (TABP EIC) in Metastatic Castration-Resistant Prostate Cancer | unknown | Early Phase 1 | 9 | Allife Medical Science and Technology Co., Ltd.INDUSTRY | 1 | Aug 1, 2022 | clinicaltrials |
| NCT04996602 | Therapeutic Efficiency and Response to 2.0 GBq (55mCi) 177Lu-EB-PSMA in Patients With mCRPC | unknown | Early Phase 1 | 30 | Peking Union Medical College HospitalOTHER | 1 | Jul 15, 2022 | clinicaltrials |
| NCT04288336 | Daily, Long-Term Intermittent Fasting for the Prevention of PSA-Recurrence in Patients With Localized Prostate Cancer After Radical Prostatectomy | withdrawn | Early Phase 1 | 0 | Mayo ClinicOTHER | 1 | Jul 11, 2022 | clinicaltrials |
| NCT04266392 | Molecular Imaging of Prostate Cancer Using Radiofluorinated PSMA Ligand | completed | Early Phase 1 | 20 | Stony Brook UniversityOTHER | 1 | May 5, 2022 | clinicaltrials |
| NCT03071328 | INJECT: A Pilot Study of Intra-tumoral Injections in Metastatic Urological Cancers | completed | Early Phase 1 | 10 | Duke UniversityOTHER | 1 | Apr 11, 2022 | clinicaltrials |
| NCT01434342 | Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients | completed | Early Phase 1 | 146 | Wake Forest University Health SciencesOTHER | 1 | Sep 28, 2021 | clinicaltrials |
| NCT04403568 | Testing the Synergism of Phytonutrients, Curcumin and Ursolic Acid, to Target Molecular Pathways in the Prostate | withdrawn | Early Phase 1 | 0 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Sep 16, 2021 | clinicaltrials |
| NCT04060043 | Pilot Study to Evaluate the Effects of a Generic Goserelin Acetate in Patients With Prostate Cancer | completed | Early Phase 1 | 11 | CMX ResearchOTHER | 2 | May 10, 2021 | clinicaltrials |
| NCT04282824 | Impact of Monosodium Glutamate on 68GA-PSMA-11, PET Imaging Biodistribution in Patients With Prostate Cancer(MSG PSMA PET) | completed | Early Phase 1 | 14 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Dec 2, 2020 | clinicaltrials |
| NCT02357121 | Focal Laser Ablation of Prostate Tissue(FLA) | completed | Early Phase 1 | 11 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 21, 2020 | clinicaltrials |
| NCT04225910 | Clinical Trial of Ac225-PSMA Radioligand Therapy of Metastatic Castration-resistant Prostate Cancer | unknown | Early Phase 1 | 20 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 0 | Jan 13, 2020 | clinicaltrials |
| NCT04113096 | Dibenzyl Trisulphide (GUINEAHEN WEED) for Stage IV Cancer | unknown | Early Phase 1 | 104 | The University of The West IndiesOTHER | 1 | Oct 8, 2019 | clinicaltrials |
| NCT00214422 | Intensity Modulated Radiation Therapy for Prostate Cancer | completed | Early Phase 1 | 19 | National Cancer Institute (NCI)NIH | 1 | Jul 19, 2019 | clinicaltrials |
| NCT02646319 | Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations | completed | Early Phase 1 | 2 | Mayo ClinicOTHER | 1 | Jun 6, 2019 | clinicaltrials |
| NCT03960788 | Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate Cancer | unknown | Early Phase 1 | 50 | University of CincinnatiOTHER | 1 | May 23, 2019 | clinicaltrials |
| NCT02190279 | 18F-DCFBC PET/CT in Prostate Cancer | completed | Early Phase 1 | 116 | National Cancer Institute (NCI)NIH | 1 | Apr 23, 2019 | clinicaltrials |
| NCT01445054 | 111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast Cancer | terminated | Early Phase 1 | 13 | National Cancer Institute (NCI)NIH | 1 | Mar 11, 2019 | clinicaltrials |
| NCT02450201 | MRI With C13 Pilot Study Prostate Cancer | terminated | Early Phase 1 | 5 | University of California, San FranciscoOTHER | 1 | Oct 23, 2018 | clinicaltrials |
| NCT02115828 | A Study of Vismodegib in Men With Metastatic CRPC With Accessible Metastatic Lesions for Tumor Biopsy | completed | Early Phase 1 | 9 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jul 20, 2018 | clinicaltrials |
Data updated 22 days agoSource updated Feb 14, 2025source: clinicaltrials